TransMedics Group, Inc. (TMDX) Capital expenditures 2018–2025
TransMedics Group, Inc. (TMDX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$59.3MFY2025 · since FY2018: $418,000 → $59.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $59.3M | -54.3% |
| FY2024 | $129.7M | -14.6% |
| FY2023 | $151.8M | +1175.3% |
| FY2022 | $11.9M | +238.4% |
| FY2021 | $3.5M | +673.4% |
| FY2020 | $455,000 | +175.8% |
| FY2019 | $165,000 | -60.5% |
| FY2018 | $418,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice